The authors observed that the rise in circulating cTnT was more likely due to subclinical myocardial damage, which had not been detected by conventional measures, rather than being caused by a release of cTnT from injured skeletal muscle into the blood pool, as observed in other neuromuscular diseases (20–22). The gene discussed is TNNT2; the disease is neuromuscular disease.